ArticleClinical case reports2017

Uncommon response of cisplatin and etoposide for treatment of advanced medullary thyroid carcinoma.

Nathamon Panomuppakarn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.